Form 4 holding
Chief Financial Officer
Dermata Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 14,337
- Estimated value
- $34,409
- Report date
- 17 Aug 2021
- Price
- $2.40
- Ownership
- By Insley Family Trust
Thomas Insley
Insider Reports History
- Reporting-owner location
- Carlsbad, CA
- Latest reporting-owner signature
-
/s/ Gerald T. Proehl, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Thomas Insley
Form 4 holding
Chief Financial Officer
Dermata Therapeutics, Inc.
- Security class
- Series 1d Preferred Stock
- Shares / value
- 0
- Estimated value
- Report date
- 17 Aug 2021
- Price
- Ownership
- By Insley Family Trust
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Thomas Insley
4
DRMA
Dermata Therapeutics, Inc.
- Report period
- 17 Aug 2021
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 17 Aug 2021, 12:40
- Role
- Chief Financial Officer
- Next action
- Open filing details
3
DRMA
Dermata Therapeutics, Inc.
- Report period
- 12 Aug 2021
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 12 Aug 2021, 19:33
- Role
- Chief Financial Officer
- Next action
- Open filing details